{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:38Z","timestamp":1791300518293,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NWO-Zon-MW"},{"name":"IMI JU"},{"name":"Dutch Arthritis Foundation"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1136\/annrheumdis-2016-210772","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:25:39Z","timestamp":1493166339000},"page":"1449-1457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Breach of autoreactive B cell tolerance by post-translationally modified proteins"],"prefix":"10.1016","volume":"76","author":[{"given":"Jacqueline S","family":"Dekkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije K","family":"Verheul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen N","family":"Stoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Ioan-Facsinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"van Veelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud H","family":"de Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M C","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Rapecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E M","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2016-210772_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.autrev.2009.06.002","article-title":"Peptidylarginine deiminase 4 and citrullination in health and disease","volume":"9","author":"Anzilotti","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-210772_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","article-title":"The influence of ACPA status and characteristics on the course of RA","volume":"8","author":"Willemze","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210772_bib3","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00296-010-1671-3","article-title":"Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan","volume":"326","author":"Shidara","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1136\/annrheumdis-2016-210772_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13075-014-0483-3","article-title":"Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts","volume":"16","author":"Humphreys","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib6","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2005.041079","article-title":"Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles","volume":"65","author":"Linn-Rasker","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib8","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/annrheumdis-2016-210772_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.38969","article-title":"Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis","volume":"67","author":"Thiele","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210772_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2016-209297","article-title":"Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs","volume":"76","author":"Figueiredo","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","article-title":"Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies","volume":"13","author":"Shi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2016-210772_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-015-0536-2","article-title":"Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage","volume":"17","author":"Brink","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210772_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"Shi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib17","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib19","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.4049\/jimmunol.1000075","article-title":"Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis","volume":"184","author":"Mydel","year":"2010","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2016-210772_bib20","first-page":"1","article-title":"Autoantibodies to posttranslational modifications in rheumatoid arthritis","volume":"2014","author":"Burska","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1136\/annrheumdis-2016-210772_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12016-014-8424-0","article-title":"The clinical significance of posttranslational modification of autoantigens","volume":"47","author":"Zavala-Cerna","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/annrheumdis-2016-210772_bib22","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/art.11229","article-title":"Citrullination of synovial proteins in murine models of rheumatoid arthritis","volume":"48","author":"Vossenaar","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"76","key":"10.1136\/annrheumdis-2016-210772_bib23","article-title":"Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis","volume":"9","author":"Stoop","year":"2014","journal-title":"PLoS One"},{"key":"10.1136\/annrheumdis-2016-210772_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/annrheumdis-2014-206797","article-title":"Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system","volume":"74","author":"Stoop","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"76","key":"10.1136\/annrheumdis-2016-210772_bib25","article-title":"Predicting arthritis outcomes\u2013what can be learned from the leiden early arthritis clinic?","volume":"50","author":"de Rooy","year":"2011","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2016-210772_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1136\/annrheumdis-2016-210772_bib27","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1186\/ar1697","article-title":"Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity","volume":"67","author":"Lundberg","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20072051","article-title":"Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice","volume":"205","author":"Hill","year":"2008","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2016-210772_bib29","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1002\/art.30639","article-title":"Immunization with porphyromonas gingivalis enolase induces autoimmunity to mammalian \u03b1-enolase and arthritis in DR4-IE-transgenic mice","volume":"63","author":"Kinloch","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2010.131102","article-title":"Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities","volume":"70","author":"Ioan-Facsinay","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib31","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib32","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar4322","article-title":"ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression","volume":"15","author":"van Beers","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib33","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0786-z","article-title":"An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting","volume":"17","author":"van Heemst","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/annrheumdis-2012-201484","article-title":"Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein\/peptide antibody fine specificity profile","volume":"72","author":"Lundberg","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"76","key":"10.1136\/annrheumdis-2016-210772_bib36","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1136\/annrheumdis-2016-210772_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3899\/jrheum.130742","article-title":"Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins\/peptides","volume":"41","author":"Scinocca","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210772_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/annrheumdis-2012-201559","article-title":"Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the \u2018AMC-Senshu\u2019 method","volume":"72","author":"Shi","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib39","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210772_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13075-016-1001-6","article-title":"Antibodies to carbamylated \u03b1-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies","volume":"18","author":"Reed","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib41","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/ar3848","article-title":"T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles","volume":"14","author":"Law","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2016-210772_bib43","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20131241","article-title":"A molecular basis for the association of the HLA-DRB1 locus, Citrullination, and rheumatoid arthritis","volume":"210","author":"Scally","year":"2013","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2016-210772_bib44","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/intimm\/dxm099","article-title":"Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition","volume":"19","author":"James","year":"2007","journal-title":"Int Immunol"},{"key":"10.1136\/annrheumdis-2016-210772_bib45","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.30445","article-title":"Identification and functional characterization of T cells reactive to Citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients","volume":"63","author":"Snir","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210772_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0890-0","article-title":"Inflammatory but not apoptotic death of granulocytes citrullinates fibrinogen","volume":"17","author":"Blach\u00e8re","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210772_bib47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2016.00461","article-title":"A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination","volume":"7","author":"Konig","year":"2016","journal-title":"Front Immunol"},{"key":"10.1136\/annrheumdis-2016-210772_bib48","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/pmic.201000812","article-title":"Protein acetylation in prokaryotes","volume":"11","author":"Jones","year":"2011","journal-title":"Proteomics"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724198664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724198664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2016-210772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:16:36Z","timestamp":1737249396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724198664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0003496724198664"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-210772","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breach of autoreactive B cell tolerance by post-translationally modified proteins","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-210772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 \u00a9 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}